No Data
No Data
Private Companies Among Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Largest Shareholders, Saw Gain in Holdings Value After Stock Jumped 31% Last Week
"Miracle drug" for reducing fever – An Gong Niu Huang Wan and Zhangzhou Pientzehuang Pharmaceutical are being recalled in many places, causing a decline in market prices | Industry News
①The price of Angong Niuhuang Pills and Zinc Ingot of Zhangzhou Pientzehuang Pharmaceuticals has dropped, with a decrease of more than 100 yuan per pill/ingot. ②With the production and marketization of cultivated musk in the body, as well as the pilot project of lifting the ban on the import of natural musk in China, industry insiders expect that the tight supply and demand situation of musk raw materials will be alleviated.
China Merchants Securities: Profit performance is better than revenue, and top OTC brands have stronger resilience.
In the first half of 2024, high-end scarce resources and traditional Chinese medicine OTC enterprises with brand and channel barriers performed well, while hospital-based traditional Chinese medicine enterprises were under short-term pressure due to industry policies and other factors.
Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Could Easily Take On More Debt
Zhangzhou Pientzehuang Pharmaceutical's (SHSE:600436) Profits May Not Reveal Underlying Issues
Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 39% And Analysts Are Revising Their Forecasts